VITIQOL questionnaire
Other16 questions questionnaire measure effect of vitiligo on quality of life
Other names: WPAI questionnaire and GSE scale
NCT Number: NCT06877000
translate and validate the vitiligo specific quality of life (VITIQOL) questionnaire to Arabic language.
evaluate the effect of vitiligo on patient quality of life using vitiligo specific quality of life questionnaire (VitiQoL).
measure the impact of vitiligo on work productivity using work productivity and activity impairment questionnaire (WPAI) and general self efficacy scale (GSE) .
analyze how disease severity and location influence patients quality of life and work pro
Trial opening soon.
Get Notified18 year–60 year
All sexes
Observational
Vitiligo is a common disorder of depigmentation caused by the progressive destruction of melanocytes that affect the skin, hair and mucous membranes, clinically presenting as depigmented macules and leukotrichia.
Vitiligo was historically regarded as a cosmetic disorder; however, it is an immune disease as it affects patient well-being . It affects approximately 0.5-1% of the global population. A Study reported a prevalence of 1.2% in the Egyptian population.
Vitiligo is asymptomatic disease, so its effect on quality of life is much more related to psychological problems, such as lack of self-confidence unpleasant body images unsuccessful social relationships, and lower quality of marital relations, than the exclusive physical issues. It has been shown that patients with vitiligo are at risk of higher social discrimination and stigma Lesions that are more severe, on the face, or covering a greater BSA are more often associated with poorer outcomes and activity impairment.
Recently a study conducted in Egypt in 2023 noted that more than half of studied sample had low level of self-esteem and quality of life. While more than half of studied sample had moderate negative body image. Also, half of studied sample had moderate level of social problems .
limited studies have been conducted in Upper Egypt which assess life quality of patients with vitiligo and but those Studies employed non-specific tools like Dermatology Life Quality Index (DLQI).
Lilly et al have developed a reliable tool with high internal consistency named as Vitiligo specific Quality of life questionnaire(VITIQOL) that consists of 16 questions comprising of demographic and clinical parameters of the patients.
Also the work productivity and activity impairment among vitiligo patients in Egypt have not been assessed before .
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
16 questions questionnaire measure effect of vitiligo on quality of life
Other names: WPAI questionnaire and GSE scale
Time frame: Baseline
A translated version will help to measure impact of vitiligo in Arabs
Time frame: Baseline
Vitiligo specific quality of life instrument have 15 questions each one has a likert scale from 0 to 6 , score ranges from 0-90 , patients with severe vitligo expect to have low score on the questionnaire
Time frame: Baseline
Work Productivity and Activity impairments questionnaire is a 6 question questionnaire consists of four consists of four metric :
Contact information is provided by the study sponsor or research team.
Esraa Sa Ahmed Abdelhady, Resident
CONTACT
Yasmin Mo Tawfik, Assprof
CONTACT
Assiut University
Other
Vitiligo Severity, Quality of Life, Work Productivity and Activity Impairment Among Patients in Upper Egypt
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07682506
Hypopigmentation, Pigmentation Disorders
Beijing, Beijing Municipality, China
View Trial DetailsNCT07647237
Hypopigmentation, Pigmentation Disorders
View Trial DetailsNCT07595939
Hypopigmentation, Pigmentation Disorders
Hangzhou, Zhejiang, China
View Trial DetailsNCT07519031
Exosomes, Hypopigmentation
Xi'an, Shaanxi, China
View Trial Details